HOME >> MEDICINE >> NEWS
New approach to imaging separates thought from perception

Miami Beach, Oct. 24, 1999 -- Using a novel approach to imaging, researchers have discovered that thinking about moving objects pre-activates areas of the brain's motion detection system before any moving objects appear. These areas would hold our expectations on-line as we prepare to cross a busy street, return a tennis serve or catch a falling child.

"This pre-activation may tune the motion detection pathway, allowing us to respond more strongly and selectively when an anticipated object appears," says Gordon L. Shulman, Ph.D., research scientist in neurology at Washington University School of Medicine in St. Louis.

Shulman and colleagues report their findings in the November issue of the Journal of Neuroscience. They will discuss additional experiments Oct. 24 and 26 during the annual meeting of the Society for Neuroscience in Miami Beach, Fla. "You could use this method anytime you wanted to separate the processes that prepare you to do a task from those involved in executing that task," Shulman says.

A major stumbling block has hampered attempts to understand how cognitive expectations such as goals, memories and thoughts influence the way we see the world. Because images obtained through positron emission tomography (PET) could not be made in less than 40 seconds, they merged expectation with perception. But the advent of functional magnetic resonance imaging (fMRI) cut the time scale to a few seconds. Using BOLD fMRI, Shulman and colleagues have devised a way to obtain separate images of expectation and perception during a single trial. For example, they can obtain one set of images while a person anticipates a visual stimulus and a second set when the stimulus appears.

"This enhanced precision in human neuroimaging allows us to track the sequential involvement of different areas of the brain at different times during a task," says co-author Maurizio Corbetta, M.D., assistant professor of neurology,
'"/>

Contact: Linda Sage
sage@medicine.wustl.edu
314-286-0119
Washington University School of Medicine
23-Oct-1999


Page: 1 2 3

Related medicine news :

1. OHSU scientists develop MRI approach to improve breast cancer detection
2. Trial reveals safer and simpler approach to treating children with cystic fibrosis
3. Services for children: Training needed to tackle complexity of new labours joined-up approach
4. Government approach to cutting hospital stays may be misleading
5. Is the 3 by 5 initiative the best approach to tackling the HIV pandemic?
6. Animal study suggests safer immunization approach to Alzheimers
7. Worldwide approach tackles kidney disease
8. Texas Childrens Hospital specialists say proactive approach best defense against flu season
9. Endoscopic approach best for repairing bone defect between brain, nasal cavity
10. University of Pittsburgh approach has lung recipients taking far fewer drugs
11. Tissue involved in brain development may offer new approach to stroke treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New approach imaging separates thought from perception

(Date:10/22/2014)... (PRWEB) October 22, 2014 On Saturday, October ... its fourth annual family health and fitness fair ¡Vive tu ... physical activity and good nutrition for better health and wellness ... which is free and open to the public, will be ... Brownsville, from 9:00 am to 1:00 pm. , “¡Vive ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 For Dr. Iris ... make money; it’s an extension of her life’s mission. Her ... venture as the owner of FirstLight HomeCare, make it clear ... important to me that my work makes a difference in ... an entrepreneurial spirit, so after much research, I felt ready ...
(Date:10/22/2014)... The Louis W. Sullivan Institute ... distribute health information technology innovation to transform quality ... development of six key guiding principles of patient-centered ... These are an expansion of the Institute of ... is respectful of and responsive to individual patient ...
(Date:10/22/2014)... Best Cheap Hosting USA is among ... site has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) ... from around the world. , “iPower is one of ... is providing various kinds of useful products for new ... offering excellent customer service and a number of features ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Lintelus, Inc., ... Sr. Vice President of Sales, will be speaking on ... Meetings Technology Expo on October 28, at the Holiday ... hosting a booth as well as a Tech Demo ... Meeting can create a more engaging event experience. , ...
Breaking Medicine News(10 mins):Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2
(Date:10/22/2014)... 22, 2014 Sanomedics International Holdings, Inc. (OTCQB: ... Global Research & Data Services, demand for thermometers is ... through 2018, as demand for more accurate digital thermometers ... the world,s largest market for thermometers, and one of ... Sanomedics International Holdings, Inc. Sanomedics International Holdings ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
(Date:10/22/2014)... LA JOLLA, Calif. , Oct. 22, ... RGLS ), a biopharmaceutical company leading ... targeting microRNAs, today announced that it has ... from an ongoing clinical study evaluating RG-101, ... for the treatment of hepatitis C virus ...
Breaking Medicine Technology:Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8
Cached News: